Company intelligence / Profile preview

Mechano Therapeutics

Philadelphia, Pennsylvania, United Statesmechano-therapeutics.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Mechano Therapeutics has developed a novel drug delivery system that uses mechanically activated microcapsules to release therapeutics in response to natural forces within joints. This approach aims to improve therapeutic outcomes in musculoskeletal health by enabling targeted, on-demand drug release with fewer systemic side effects. The company’s technology is still in preclinical development with no reported clinical trial results yet.

Therapeutic areas: Rheumatology
Modalities: Small moleculesProteinsBiologics
Industry: Biotech

Partnerships

PCI Ventures UPstart program at University of PennsylvaniaCreative Destruction Lab participant/investorNational Science Foundation grant recipient/investor

Beyond the preview

Go deeper on Mechano Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mechano Therapeutics.

Explore the full profile